START - Early Thrombocyte Administration to Patients With Ruptured Abdominal Aortic Aneurism
Not Applicable
- Conditions
- Ruptured Abdominal Aortic Aneurism
- Interventions
- Procedure: Platelet
- Registration Number
- NCT01291290
- Lead Sponsor
- Rigshospitalet, Denmark
- Brief Summary
The purpose of this study is to investigate the effect of platelet infusion prior to transfer to a vascular surgical department in patients with a ruptured abdominal aortic aneurism.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 420
Inclusion Criteria
- diagnosed with rAAA either by clinical evaluation or CT or UL
Exclusion Criteria
- formerly randomized in the study
- aneurism not ruptured during operation
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Thrombocyte Platelet Early thrombocyte administration to patients with rAAA
- Primary Outcome Measures
Name Time Method Mortality 30 days Mortality during the first 30days after randomization, and time to death during the 30 days.
- Secondary Outcome Measures
Name Time Method Acute myocardial infarction 30 days Development of AMI during the first 30 days after randomization, and the time to development during the first 30 days.
Length of stay in ICU until discharged from ICU Length of stay in ICU
Post operative kidney failure 30 days The need for dialysis during the first 30 days, time to start of dialysis and length.
Post operative pulmonary insufficiency 30 days Length of respirator treatment in the ICU during the first 30 days.
Length of stay in hospital until discharged from hospital Until discharged from main surgical department or if transferred to local hospital, when the patient leave local hospital.
Trial Locations
- Locations (1)
Rigshospitalet
🇩🇰Copenhagen, Oesterbro, Denmark